What does the evidence say about Creatine Sleep Deprivation Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Creatine Sleep Deprivation Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Introduction Insufficient sleep increases the risk of weight gain and metabolic dysfunction, while obesity is linked to disrupted sleep and metabolic impairment. [Good L (2026); evidence level 4] - Results In response to TSD compared with NS, tryptophan levels increased (+12%, FDR Conclusions Acute sleep loss elicits both shared and body-weight-specific changes in circulating metabolites in young adults. [Good L (2026); evidence level 4] - Given that acute sleep loss is a common metabolic stressor that increases cardiometabolic risk, these differences may contribute to mechanistic hypotheses about the heightened vulnerability to metabolic dysregulation in individuals with obesity who are frequently exposed to sleep loss. [Good L (2026); evidence level 4] - Although both conditions are tightly interconnected, it remains unclear whether body weight status determines how acute sleep loss alters metabolite levels. [Good L (2026); evidence level 4] - The present study investigates whether supplementation of a lower dose is associated with cognitive effects during sleep deprivation, focusing exclusively on cognitive performance outcomes. [Gordji-Nejad A (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.